At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,001 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days Gestation
In Brief
An observational study for Medical; Abortion, Fetus. Completed, enrolled 1,001 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the efficacy and acceptability of a regimen of 200 mg mifepristone (Zacafemyl), followed 24-48 hours later by 800 mcg of buccal misoprostol.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMedical; Abortion, Fetus
CountriesUnited States
CollaboratorsSecretaria de Salud, Mexico
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2011
Primary CompletionMay 2012
First PostedOct 2013
TodayJul 2026
First PostedOct 22, 2013
Enrollment StartAug 1, 2011
Primary CompletionMay 1, 2012
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 12.7 years ago